Lindsey Clark
Family · Findlay, OHNPI 1174294979
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 312 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 36 manufacturers reported payments, led by AbbVie at 27.1% of the total. 2025 is the largest year on record at $1,902, more than ten times the $15 reported in 2021. Among family clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 312 payments — averaging $16.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$651
- Lilly USA, LLC$399
- Merck$207
- Otsuka America Pharmaceutical, Inc.$201
- Amgen$196
- plus $2K from 30 others
What the payments were for
- Food & beverage$5,044100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 80 | $1,368 |
| Novo Nordisk | 48 | $651 |
| Lilly USA, LLC | 24 | $399 |
| Merck | 12 | $207 |
| Otsuka America Pharmaceutical, Inc. | 11 | $201 |
| Amgen | 12 | $196 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $183 |
| Esperion Therapeutics, Inc. | 11 | $179 |
| Axsome Therapeutics, Inc. | 9 | $154 |
| AstraZeneca | 9 | $151 |
| Aimmune Therapeutics, Inc. | 7 | $120 |
| Boehringer Ingelheim | 8 | $120 |
| Bayer | 7 | $109 |
| Phathom Pharmaceuticals, Inc. | 9 | $104 |
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $96 |
| Novartis | 5 | $78 |
| Exact Sciences | 4 | $70 |
| Sumitomo Pharma America, Inc. | 4 | $69 |
| Xeris Pharmaceuticals, Inc. | 3 | $69 |
| GSK | 4 | $67 |
| Nestle Healthcare Nutrition Inc. | 3 | $56 |
| Currax Pharmaceuticals LLC | 4 | $55 |
| Dexcom, Inc. | 3 | $49 |
| E.r. Squibb & Sons, L.L.C. | 3 | $46 |
| Corcept Therapeutics | 2 | $34 |
| Abbott | 2 | $33 |
| Pfizer | 2 | $32 |
| Jazz Pharmaceuticals Inc. | 1 | $23 |
| Harmony Biosciences LLC | 1 | $21 |
| Shield Therapeutics Inc | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Cranial Technologies, Inc | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$234
How this compares
$5,044 in reported general payments places this provider in the 90th percentile of 6,812 family providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SynthroidLevothyroxine Sodium | 16 | $898 |
| Escitalopram Oxalate | 40 | $599 |
| Ezetimibe | 13 | $596 |
| Rosuvastatin Calcium | 43 | $586 |
| Pantoprazole Sodium | 29 | $528 |
| Levothyroxine Sodium | 49 | $466 |
| Gabapentin | 33 | $451 |
| Atorvastatin Calcium | 96 | $404 |
| Lansoprazole | 15 | $349 |
| Metoprolol Succinate | 37 | $347 |
| Lisinopril | 81 | $336 |
| Omeprazole | 65 | $327 |
| Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen | 11 | $300 |
| Potassium Chloride | 16 | $299 |
| Bupropion XlBupropion Hcl | 12 | $284 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieSynthroid | $1,368 | $89816 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,812 family providers in Ohio.
Other family in Findlay
- Amy DonnellyFindlay$36K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
- Florence StewartNew Albany$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.